Felipe C Geyer
Overview
Explore the profile of Felipe C Geyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
4107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thompson B, Chala L, Shimizu C, Mano M, Filassi J, Geyer F, et al.
Eur Radiol
. 2021 Oct;
32(3):1663-1675.
PMID: 34716780
Purpose: Radiologic complete response (rCR) in breast cancer patients after neoadjuvant chemotherapy (NAC) does not necessarily correlate with pathologic complete response (pCR), a marker traditionally associated with better outcomes. We...
2.
Sheng Q, DAlessio J, Menezes D, Karim C, Tang Y, Tam A, et al.
Mol Cancer Ther
. 2021 Apr;
20(7):1270-1282.
PMID: 33879555
The cell surface glycoprotein P-cadherin is highly expressed in a number of malignancies, including those arising in the epithelium of the bladder, breast, esophagus, lung, and upper aerodigestive system. PCA062...
3.
Moukarzel L, Ferrando L, Da Cruz Paula A, Brown D, Geyer F, Pareja F, et al.
Mol Oncol
. 2020 Oct;
15(4):1024-1039.
PMID: 33021035
Metaplastic breast carcinoma (MBC) and uterine carcinosarcoma (UCS) are rare aggressive cancers, characterized by an admixture of adenocarcinoma and areas displaying mesenchymal/sarcomatoid differentiation. We sought to define whether MBCs and...
4.
Weigelt B, Vargas H, Selenica P, Geyer F, Mazaheri Y, Blecua P, et al.
JCO Precis Oncol
. 2020 Sep;
3.
PMID: 32914032
No abstract available.
5.
Pareja F, Da Cruz Paula A, Gularte-Merida R, Vahdatinia M, Li A, Geyer F, et al.
NPJ Breast Cancer
. 2020 Jun;
6:20.
PMID: 32550265
Primary pleomorphic adenomas (PAs) and mucoepidermoid carcinomas (MECs) of the breast are vanishingly rare. Here we sought to determine whether breast PAs and MECs would be underpinned by the fusion...
6.
Jimenez-Sanchez A, Cybulska P, Mager K, Koplev S, Cast O, Couturier D, et al.
Nat Genet
. 2020 Jun;
52(6):582-593.
PMID: 32483290
In metastatic cancer, the degree of heterogeneity of the tumor microenvironment (TME) and its molecular underpinnings remain largely unstudied. To characterize the tumor-immune interface at baseline and during neoadjuvant chemotherapy...
7.
Pareja F, Brown D, Lee J, Da Cruz Paula A, Selenica P, Bi R, et al.
Clin Cancer Res
. 2020 Mar;
26(14):3682-3693.
PMID: 32220886
Purpose: Ductal carcinoma (DCIS) is a nonobligate precursor of invasive breast cancer. Here, we sought to investigate the level of intralesion genetic heterogeneity in DCIS and the patterns of clonal...
8.
Pareja F, da Silva E, Frosina D, Geyer F, Lozada J, Basili T, et al.
Mod Pathol
. 2020 Jan;
33(6):1056-1064.
PMID: 31896809
Tall cell carcinoma with reverse polarity is a rare subtype of breast carcinoma with solid and papillary growth and nuclear features reminiscent of those of the tall cell variant of...
9.
Pareja F, Toss M, Geyer F, da Silva E, Vahdatinia M, Sebastiao A, et al.
Histopathology
. 2019 Dec;
76(6):865-874.
PMID: 31887226
Aims: Breast adenomyoepitheliomas (AMEs) are uncommon tumours. Most oestrogen receptor (ER)-positive AMEs have mutations in phosphoinositide 3-kinase (PI3K) pathway genes, whereas ER-negative AMEs usually harbour concurrent mutations affecting the HRAS...
10.
Li A, Geyer F, Blecua P, Lee J, Selenica P, Brown D, et al.
NPJ Breast Cancer
. 2019 Nov;
5:44.
PMID: 31754629
[This corrects the article DOI: 10.1038/s41523-019-0115-9.].